Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 401 | 2022 |
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung … M Taron, Y Ichinose, R Rosell, T Mok, B Massuti, L Zamora, JL Mate, ... Clinical Cancer Research 11 (16), 5878-5885, 2005 | 391 | 2005 |
Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome) S Beà, A López-Guillermo, M Ribas, X Puig, M Pinyol, A Carrió, L Zamora, ... The American journal of pathology 161 (3), 957-968, 2002 | 137 | 2002 |
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms L Palomo, M Meggendorfer, S Hutter, S Twardziok, V Ademà, I Fuhrmann, ... Blood, The Journal of the American Society of Hematology 136 (16), 1851-1862, 2020 | 129 | 2020 |
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols J Ribera, M Morgades, L Zamora, P Montesinos, I Gómez‐Seguí, ... Cancer 121 (21), 3809-3817, 2015 | 63 | 2015 |
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia JM Ribera, M Morgades, J Ciudad, P Montesinos, J Esteve, E Genescà, ... Blood, The Journal of the American Society of Hematology 137 (14), 1879-1894, 2021 | 61 | 2021 |
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis F Ramos, C Robledo, FM Izquierdo-García, D Suárez-Vilela, R Benito, ... Oncotarget 7 (21), 30492, 2016 | 46 | 2016 |
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia L Palomo, M Ibanez, M Abáigar, I Vazquez, S Alvarez, M Cabezon, ... British Journal of Haematology 188 (5), 605-622, 2020 | 44 | 2020 |
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia E Genescà, M Morgades, P Montesinos, P Barba, C Gil, R Guàrdia, ... Haematologica 105 (6), e294, 2020 | 39 | 2020 |
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual … A Bataller, G Oñate, M Diaz‐Beyá, F Guijarro, A Garrido, S Vives, ... British Journal of Haematology 191 (1), 52-61, 2020 | 35 | 2020 |
Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia B Xicoy, U Germing, MJ Jimenez, O Garcia, R Garcia, J Schemenau, ... European journal of haematology 97 (1), 33-38, 2016 | 35 | 2016 |
Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies MSV Ferreira, M Kirschner, I Halfmeyer, N Estrada, B Xicoy, S Isfort, ... Annals of the New York Academy of Sciences 1466 (1), 93-103, 2020 | 34 | 2020 |
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features L Palomo, O Garcia, M Arnan, B Xicoy, F Fuster, M Cabezón, R Coll, ... Oncotarget 7 (35), 57021, 2016 | 31 | 2016 |
Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia E Lloveras, I Granada, L Zamora, B Espinet, L Florensa, C Besses, ... Cancer genetics and cytogenetics 148 (1), 71-76, 2004 | 30 | 2004 |
Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential … L Florensa, C Besses, L Zamora, B Bellosillo, B Espinet, S Serrano, ... Blood 103 (6), 2427-2428, 2004 | 29 | 2004 |
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol A Bataller, A Garrido, F Guijarro, G Oñate, M Diaz-Beyá, M Arnan, ... Blood advances 6 (4), 1193-1206, 2022 | 27 | 2022 |
Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis L Zamora, B Xicoy, M Cabezón, C Fernandez, S Marcé, P Velez, M Xandri, ... Leukemia & Lymphoma 56 (10), 2973-2974, 2015 | 27 | 2015 |
Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL C Bueno, JR Tejedor, R Bashford-Rogers, L Gonzalez-Silva, ... Blood, The Journal of the American Society of Hematology 134 (11), 900-905, 2019 | 26 | 2019 |
Copy number profiling of adult relapsed B‐cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms J Ribera, L Zamora, M Morgades, M Mallo, N Solanes, M Batlle, S Vives, ... Genes, Chromosomes and Cancer 56 (11), 810-820, 2017 | 24 | 2017 |
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer … M Cabezón, R Malinverni, J Bargay, B Xicoy, S Marcé, A Garrido, ... Clinical epigenetics 13, 1-14, 2021 | 23 | 2021 |